Skip to main content
Clinical Trials/ISRCTN70758207
ISRCTN70758207
Completed
未知

Therapist-guided, parent-assisted remote digital behavioural intervention for tics in children and adolescents with Tourette syndrome: an internal pilot study and single-blind randomised controlled trial

ottinghamshire Healthcare NHS Foundation Trust0 sites224 target enrollmentMarch 20, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Tourette Syndrome or Chronic Tic Disorder
Sponsor
ottinghamshire Healthcare NHS Foundation Trust
Enrollment
224
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30610027 protocol 2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31898510 protocol (added 06/01/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34480868/ (added 06/09/2021) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35416566/ Comparison of tic symptoms before and during COVID-19 pandemic (added 14/04/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36649686/ outcome results (added 18/01/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37924247/ (added 06/11/2023)

Registry
who.int
Start Date
March 20, 2018
End Date
April 12, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ottinghamshire Healthcare NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 9 to 17 years
  • 2\. Suspected or confirmed Tourette syndrome/chronic tic disorder, including moderate/severe tics: score \>15 on the Yale Global Tic Severity Scale (YGTSS) Total Tic Severity Score (TTSS); TTSS score\>10 if motor or vocal tics only
  • 3\. Competent to provide written, informed consent (parental consent for child aged \<16\)
  • 4\. Broadband internet access and regular PC/laptop/Mac user, with mobile phone SMS

Exclusion Criteria

  • 1\. Previous structured behavioural intervention for tics e.g. HRT/CBIT or exposure and response prevention within last 12 months from baseline. Participants may start any new behavioural interventions for tics outside of the trial intervention only after the initial 6 months of the study
  • 2\. Change to medication for tics (starting or stopping medication) within the previous 2 months prior to baseline. Participants may start/change medication for tics only after the initial 6 months of the study
  • 3\. Diagnosis of alcohol/substance dependence, psychosis, suicidality, or anorexia nervosa
  • 4\. Moderate/severe intellectual disability
  • 5\. Immediate risk to self or others
  • 6\. Parent or child not able to speak or read English

Outcomes

Primary Outcomes

Not specified

Similar Trials